Original Article

HEARING LOSS AND ANTIOXIDANTS IN CHRONIC HEMODIALYSIS PATIENTS

Volume 7 · Issue 2 Publish Date: March 20, 2019
Full Text PDF
Enver ALTAŞ
Atatürk Üniversitesi, Tıp Fakültesi, Kulak Burun Boğaz, Anabilim Dalı, ERZURUM
Ramazan ÇETİNKAYA
Atatürk Üniversitesi, Tıp Fakültesi, Nefroloji Bilim Dalı, ERZURUM
Ahmet KIZILTUNÇ
Atatürk Üniversitesi, Tıp Fakültesi, Biyokimya, Anabilim Dalı, ERZURUM
H. Zeki TONBUL
Atatürk Üniversitesi, Tıp Fakültesi, Nefroloji Bilim Dalı, ERZURUM
Harun ÜÇÜNCÜ
Atatürk Üniversitesi, Tıp Fakültesi, Kulak Burun Boğaz, Anabilim Dalı, ERZURUM
İlyas ÇAPOĞLU
Atatürk Üniversitesi, Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, ERZURUM
ALTAŞ, E., ÇETİNKAYA, R., KIZILTUNÇ, A., TONBUL, H. Z., ÜÇÜNCÜ, H., & ÇAPOĞLU, İlyas. (2019). HEARING LOSS AND ANTIOXIDANTS IN CHRONIC HEMODIALYSIS PATIENTS. Turkish Journal of Nephrology, 7(2), 97–101. Retrieved from https://www.turkjnephrol.org/index.php/pub/article/view/119
Full Text Full Text PDF

Abstract

No satisfactory explanation has been made about chronic hemodialysis-induced hearing loss, yet. This study has been aimed to investigate whether there is a possible role of changes in antioxidant defense mechanisms in chronic hemodialysis-induced hearing loss. Sixty-six patients with chronic renal failure and 22 healthy volunteers were included in the study. The patients were divided into two groups as group 1 and 2 on the basis of the presence and absence of hearing loss, respectively. Forty-seven of 66 patients had hearing loss and nine-ten had not hearing loss. The controls were admitted as group 3. In all patients and controls audiologic tests were performed and the activities of antioxidants, and blood urea nitrogen, creatinin, uric acid, and albumin, and hearing threshold values were determined.

This study showed that decreasing in antioxidant enzymes activities in chronic hemodialysis patients might have an important role in hearing loss.

Similar Articles

Article Info
Published In
Journal Turkish Journal of Nephrology
Volume / Issue Volume 7 · Issue 2
Pages 97-101
History
Published Online March 20, 2019
Copyright
Affiliations
Enver ALTAŞ
Atatürk Üniversitesi, Tıp Fakültesi, Kulak Burun Boğaz, Anabilim Dalı, ERZURUM
Ramazan ÇETİNKAYA
Atatürk Üniversitesi, Tıp Fakültesi, Nefroloji Bilim Dalı, ERZURUM
Ahmet KIZILTUNÇ
Atatürk Üniversitesi, Tıp Fakültesi, Biyokimya, Anabilim Dalı, ERZURUM
H. Zeki TONBUL
Atatürk Üniversitesi, Tıp Fakültesi, Nefroloji Bilim Dalı, ERZURUM
Harun ÜÇÜNCÜ
Atatürk Üniversitesi, Tıp Fakültesi, Kulak Burun Boğaz, Anabilim Dalı, ERZURUM
İlyas ÇAPOĞLU
Atatürk Üniversitesi, Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, ERZURUM
Cite this Article
ALTAŞ, E., ÇETİNKAYA, R., KIZILTUNÇ, A., TONBUL, H. Z., ÜÇÜNCÜ, H., & ÇAPOĞLU, İlyas. (2019). HEARING LOSS AND ANTIOXIDANTS IN CHRONIC HEMODIALYSIS PATIENTS. Turkish Journal of Nephrology, 7(2), 97–101. Retrieved from https://www.turkjnephrol.org/index.php/pub/article/view/119
Outlines